Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion

View source ↗

Summary

ClinicalTrials.gov entry evaluating the safety and effectiveness of GENOSS PCB for long femoropopliteal artery lesions in patients undergoing peripheral vascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GENOSS PCB (paclitaxel-coated balloon)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease | Status: NOT_YET_RECRUITING